Top compounds associated with response to ZYG11B


Feature Type Standardized
Nominal ANOVA
mRNA ZG-10 GDSC1000 pan-cancer AAC 0.22 3e-06
mRNA AZD-2281 CTRPv2 pan-cancer AAC 0.17 3e-06
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 2e-05
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 5e-05
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.15 9e-05
mRNA BRD-A02303741:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 0.0001
mRNA pac-1 GDSC1000 pan-cancer AAC -0.15 0.0001
mRNA Erlotinib CTRPv2 pan-cancer AAC -0.14 0.0001
mRNA Cerulenin CTRPv2 pan-cancer AAC 0.14 0.0001
mRNA EKB-569 GDSC1000 pan-cancer AAC -0.14 0.0002
Download CSV